SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-16-033633
Filing Date
2016-06-10
Accepted
2016-06-10 07:12:58
Documents
4
Period of Report
2016-07-21
Effectiveness Date
2016-06-10

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A dffn20160607_def14a.htm DEF 14A 1097675
2 proxypage2.jpg GRAPHIC 129563
3 proxypage1.jpg GRAPHIC 301792
4 a1.jpg GRAPHIC 27888
  Complete submission text file 0001437749-16-033633.txt   1727916
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-24477 | Film No.: 161707363
SIC: 2834 Pharmaceutical Preparations